+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

South Korea Cancer Stem Cell Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

South Korea Cancer Stem Cell Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • South Korea
From
United States Cancer Stem Cell Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

United States Cancer Stem Cell Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • United States
From
Vietnam Cancer Stem Cell Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Vietnam Cancer Stem Cell Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • Vietnam
From
Saudi Arabia Prostate Cancer Biomarker Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Saudi Arabia Prostate Cancer Biomarker Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • March 2022
  • 40 Pages
  • Saudi Arabia
From
India Prostate Cancer Biomarker Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

India Prostate Cancer Biomarker Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • March 2022
  • 40 Pages
  • India
From
Prostate Cancer Biomarker Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027 - Product Thumbnail Image

Prostate Cancer Biomarker Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

  • Report
  • March 2022
  • 100 Pages
  • Global
From
Cancer Stem Cell Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027 - Product Thumbnail Image

Cancer Stem Cell Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

  • Report
  • March 2022
  • 100 Pages
  • Global
From
Saudi Arabia Thymus Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Saudi Arabia Thymus Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • December 2021
  • 40 Pages
  • Saudi Arabia
From
India Thymus Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

India Thymus Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • December 2021
  • 40 Pages
  • India
From
Urethral Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Urethral Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 64 Pages
  • Global
From
Transforming Growth Factor Beta 1 (TGFB1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Transforming Growth Factor Beta 1 (TGFB1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 112 Pages
  • Global
From
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 62 Pages
  • Global
From
Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 42 Pages
  • Global
From
Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 44 Pages
  • Global
From
Smoothened Homolog (Protein Gx or SMO) - Drugs In Development, 2021 - Product Thumbnail Image

Smoothened Homolog (Protein Gx or SMO) - Drugs In Development, 2021

  • Report
  • December 2021
  • 91 Pages
  • Global
From
Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021 - Product Thumbnail Image

Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
Vaginal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Vaginal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 475 Pages
  • Global
From
Retinoblastoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Retinoblastoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 72 Pages
  • Global
From
Head And Neck Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 3419 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more